Claudia Epelbaum, | |
26 Central St, Somerville, MA 02143-2827 | |
(617) 591-6300 | |
Not Available |
Full Name | Claudia Epelbaum |
---|---|
Gender | Female |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 26 Central St, Somerville, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295848513 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 223190 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Claudia Epelbaum, 26 Central St, Somerville, MA 02143-2827 Ph: () - | Claudia Epelbaum, 26 Central St, Somerville, MA 02143-2827 Ph: (617) 591-6300 |
News Archive
USA Today: "The key early program of the nation's new health law aims to provide affordable coverage to about 200,000 people with pre-existing medical conditions, such as cancer or diabetes, through federal high-risk insurance pools. The law called for the program to be in place last week, 90 days after its enactment, though the Department of Health and Human Services had said the programs would launch Thursday to coincide with the start of states' fiscal years."
Vitamin D is important for optimal reproductive function in both animals and humans. It has long been known that serum vitamin D level is important for reproductive function in various animals, but now researchers from the University of Copenhagen and Copenhagen University Hospital have shown that this relationship can also be demonstrated in humans.
Leptospirosis infections, caused by Leptospira bacteria, occur in people and animals around the world, but different strains of the bacteria may vary in their ability to cause disease and to jump between species.
Ember Therapeutics, Inc., a privately held, New York-based biopharmaceutical company that is developing targeted therapies for osteoarthritis, kidney fibrosis, and other indications using Bone Morphogenetic Protein (BMP)-7, announced today initial results from the Phase II(a) trial of local BMP-7 administration in patients with moderate osteoarthritis of the knee.
› Verified 7 days ago
Theodore Peter Wasik, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 61 Roseland St Ste 8, Somerville, MA 02143 Phone: 617-470-1805 Fax: 617-714-5383 | |
Judith L Herman, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 26 Central St, Somerville, MA 02143 Phone: 617-591-6114 | |
Robert T Dunn, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 26 Central St, Somerville, MA 02143 Phone: 617-591-6124 | |
Dr. Amanda J Gruber, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 41 Russell St, Somerville, MA 02144 Phone: 617-832-5800 | |
John H Lloyd, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 175 Elm St, Suite C4, Somerville, MA 02144 Phone: 617-413-1486 | |
Peter Daniolos, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 26 Central St, Somerville, MA 02143 Phone: 617-665-3220 |